Differential PI3Kδ Signaling in CD4+ T-cell Subsets Enables Selective Targeting of T Regulatory Cells to Enhance Cancer Immunotherapy

Ahmad, ShamimAbu-Eid, RashaShrimali, RajeevWebb, MasonVerma, VivekDoroodchi, AtbinBerrong, ZuzanaSamara, RaedRodriguez, Paulo C.Mkrtichyan, MikayelKhleif, Samir N.2018-01-262018-01-262017-04-15Ahmad, S, Abu-Eid, R, Shrimali, R, Webb, M, Verma, V, Doroodchi, A, Berrong, Z, Samara, R, Rodriguez, P C, Mkrtichyan, M & Khleif, S N 2017, 'Differential PI3Kδ Signaling in CD4+ T-cell Subsets Enables Selective Targeting of T Regulatory Cells to Enhance Cancer Immunotherapy', Cancer Research, vol. 77, no. 8, pp. 1892-1904. https://doi.org/10.1158/0008-5472.CAN-16-18390008-5472http://hdl.handle.net/2164/9945Copyright ©2017, American Association for Cancer Research.131591582engSDG 3 - Good Health and Well-beingR MedicineSupplementary DataRDifferential PI3Kδ Signaling in CD4+ T-cell Subsets Enables Selective Targeting of T Regulatory Cells to Enhance Cancer ImmunotherapyJournal article10.1158/0008-5472.CAN-16-1839778